Containing Or Obtained From Vaccinium (e.g., Bilberry, Cranberry, Blueberry, Etc.) Patents (Class 424/732)
  • Patent number: 10493118
    Abstract: A method for treating a subject suffering from a neurodegenerative disease includes administering at least one triterpenoid which can be obtained from Hedera helix. A method for treating a subject suffering from a neurodegenerative disease includes administering an effective amount of a Hedera helix extract which comprises the triterpenoid. The neurodegenerative disease is preferably but not exclusively Parkinson's disease or Huntington's disease. Methods for extracting the triterpenoid from Hedera helix and a method for inducing autophagy in cells by contacting them with the triterpenoid are also provided. The triterpenoid allows an exceptional induction of autophagy, in particular a significant reduction of the protein level of mutant huntingtin, a significant reduction of the protein level of A53T ?-synuclein, a significant inhibition of the oligomerization of ?-synuclein and a significant inhibition of the inclusion formation of huntingtin via the AMPK-mTOR dependent autophagy inducing pathway.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: December 3, 2019
    Assignee: MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Yuen Kwan Law, Kam Wai Wong, An Gao Wu, Liang Liu, Zeng Wu
  • Patent number: 10406091
    Abstract: The invention relates to a skin anti-ageing composition. In particular a skin anti-ageing composition comprising myricetin or glycoside thereof, and at least one LXR alpha agonist. By skin ageing is meant the appearance or manifestation of any one or more of wrinkles or sagging, poor skin barrier such as dryness, scalp itch, or uneven skin tone such as age spots.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: September 10, 2019
    Assignee: Conopco, Inc.
    Inventors: Gail Jenkins, Silvina Beatriz Lotito, Jennifer Elizabeth Pople, Linda Jane Wainwright
  • Patent number: 10005809
    Abstract: The present invention relates to 5-O-[6?-(3-hydroxy-3-methyl glutarate)?-D-glucoside as a new antioxidant.
    Type: Grant
    Filed: February 5, 2013
    Date of Patent: June 26, 2018
    Inventors: M. Iqbal Choudhary, Juveria Siddiqui, Ahmed Abbaskhan, Suad Naheed, Achyut Adhikari, Jalauddine A. Jalal Awalia
  • Patent number: 9895341
    Abstract: Therapeutic use of extracts containing proanthocyanidin including treating disorders, e.g., inflammatory disorders, e.g., inflammatory bowel disease, Crohn's disease, ulcerative colitis, indeterminate colitis, microscopic colitis, collagenous colitis, and irritable bowel syndrome. Methods of increasing a subject's immunological resistance to an infection and/or treating the infection. The infection can be, e.g., a bacterial, viral, or fungal infection. The methods can include, e.g., selecting a subject that has, or is at risk of developing, an infection, e.g., a bacterial, viral, or fungal infection, or a combination thereof; providing a composition comprising at least about 10% proanthocyanidin by weight; and administering to the subject an amount of the composition to the subject, to thereby increase a subject's immunological resistance to an infection and/or to treat the infection.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: February 20, 2018
    Assignees: Ocean Spray Cranberries, Inc., University Of Florida Research Foundation, Incorporated
    Inventors: Christina Khoo, DeAnn Liska, Susan S. Percival
  • Patent number: 9789150
    Abstract: Compositions and methods for inducing hair growth and improving hair quality utilizing extracts of blackberry in an amount effective to induce hair growth when applied topically to an area of the skin on which hair growth is desired.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: October 17, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Elizabeth Bruning, Euen Thomas Graham Ekman Gunn, Frank Liebel, Samantha Tucker-Samaras, Dina VanWyck, Delores Santora
  • Patent number: 9770476
    Abstract: The present invention provides compositions having synergistic antioxidant properties in the modulation of Toll-like receptor signaling for the promotion of homeostasis, immunity, energy conservation, protection of neural cells and anti-inflammatory responses, said compositions comprising plant and/or fruit extracts and a natural sweetener with high oxidation potential as defined by ORAC value.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: September 26, 2017
    Assignee: Justbio Inc.
    Inventor: Sophie Chabot
  • Patent number: 9314494
    Abstract: A composition prepared from a cranberry hull enzyme-treated composition which reduces or inhibits the adhesion of microorganisms to cells having ?-Gal-(1-4)-Gal terminal oligosaccharide receptors for adhesion.
    Type: Grant
    Filed: May 25, 2012
    Date of Patent: April 19, 2016
    Assignees: The United States of America, as Represented by the Secretary of Agriculture, Ocean Spray Cranberries, Inc
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Christina Khoo, Gary D. Strahan
  • Patent number: 9248154
    Abstract: A composition for treatment of urinary tract infection derived primarily from pomegranate and cranberry fruit components is disclosed. The composition may be derived from juices, concentrates, liquid extracts, or powdered extracts, e.g. dehydrated pomegranate juice, of pomegranate and cranberry fruits. The concentration of each of the component (i.e. pomegranate product and cranberry product) in the composition is set such as to achieve optimum synergistic effects by increasing urinary tract anti-adhesion activity.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: February 2, 2016
    Assignee: POM Wonderful, LLC
    Inventor: Ari Mackler
  • Patent number: 9180155
    Abstract: Described are four, novel supercritical fluid extracts of Nigella sativa seeds containing about 0.01 to about 40% (w/w) thymoquinone that can be produced using commercial-scale quantities of N. sativa seeds. These formulations provide antioxidant, thermogenic, anti-inflammatory and other biological activities qualitatively and quantitatively distinct from thymoquinone alone and are useful as dietary supplements or therapeutics for inflammation-related disorders.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: November 10, 2015
    Assignee: Bio Nexus, Ltd
    Inventors: John George Babish, Linda M. Pacioretty, Jan Debenedetto
  • Patent number: 9040099
    Abstract: A botanical composition made from a plurality of plant materials selected from Gota Kola (Centella asiatica), Turmeric Root (Curcuma longa), White Willow (Salix alba), Rosehips (Rosa canina), Hibiscus (Hibiscus sabdariffa), Evening Primrose (Oenothera biennis), and Bilberry (Vaccinium myrtillus), or phytochemicals or extracts or oils derived from the plant materials has beneficial application in addressing retinopathy and recurring peripheral neuropathy. The botanical composition can include a number of additional agents such as antioxidants, benfotiamine, thiamine (vitamin B1), and lipoic acid.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: May 26, 2015
    Assignee: Seven Consulting, Inc.
    Inventor: Michael Sugerman
  • Patent number: 9028887
    Abstract: Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: May 12, 2015
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: James A. Joseph, Agnes M. Rimando, Barbara Shukitt-Hale
  • Patent number: 9023399
    Abstract: A water-soluble anti-inflammatory cream is disclosed. The cream is a composition of between about 7.5% and about 30% by weight of a healing oil; between about 1% and about 6% by weight of an herbal extract; between about 0% and about 3.5% by weight of microencapsulated amino acids; and at least 39.4% by weight water.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: May 5, 2015
    Assignee: NU Technology, LLC
    Inventors: Irina V Filippova, Leonid K. Filippov
  • Publication number: 20150118330
    Abstract: Compositions and methods for treating diabetes are presented herein. In particular, the present disclosure reaches compositions and methods for treating diabetes utilizing a gastrointestinal microbiome modulating composition.
    Type: Application
    Filed: January 8, 2015
    Publication date: April 30, 2015
    Applicant: MICROBIOME THERAPEUTICS LLC
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W. Peno
  • Publication number: 20150086490
    Abstract: Described herein are compositions comprising a MMP-13 inhibitor, and methods of using the same.
    Type: Application
    Filed: October 2, 2014
    Publication date: March 26, 2015
    Inventors: Wei Wang, Virginia Barnes, Harsh M. Trivedi, Tao Xu
  • Patent number: 8894978
    Abstract: A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing.
    Type: Grant
    Filed: April 25, 2014
    Date of Patent: November 25, 2014
    Inventor: William Scott Prendergast
  • Patent number: 8895079
    Abstract: A blood lipid lowering agent that functions through a same mechanism as berberine (e.g. berberine, one or more pharmacologically acceptable salts of berberine or a mixture thereof) and a blood lipid lowering agent that functions through a different mechanism than berberine (e.g. phytosterols, phytostanols, esters thereof or mixtures thereof) act synergistically to improve blood lipid profiles, for example, lowering total cholesterol, LDL-C or nonHDL-C, and triglyceride, and increasing the ratio of HDL-C to nonHDL-C. The two may be used in combination to treat or reduce the chance of contracting cardiovascular disease, hyperlipidemia, atherosclerosis, coronary heart disease, angina, cerebrovascular disease, stroke, overweight or obesity, diabetes, insulin resistance, hyperglycemia, hypertension, arrhythmia, diseases of the central nervous system, diseases of the peripheral nervous system and/or inflammation.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: November 25, 2014
    Assignee: National Research Council of Canada
    Inventors: Yanwen Wang, Jeffrey Zidichouski
  • Patent number: 8883179
    Abstract: Described herein are compositions comprising a MMP-13 inhibitor, and methods of using the same.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: November 11, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Wei Wang, Virginia Barnes, Harsh M. Trivedi, Tao Xu
  • Publication number: 20140322358
    Abstract: The present invention is generally directed to compositions and methods for amelioration chronic renal failure and related symptoms in domestic animals. In one case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Fruit- and Vegetable-Based Additive. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Cesium and/or Rubidium salt. In another case, the present invention is directed to a composition for the treatment of chronic renal failure in a domestic animal or symptoms related to chronic renal failure. The composition comprises a Dehydrated Domestic Animal Food and a Phosphate Binder.
    Type: Application
    Filed: April 24, 2014
    Publication date: October 30, 2014
    Inventor: Jeffrey Alan McKinney
  • Publication number: 20140294997
    Abstract: A formulation to increase the ratio of gastrointestinal microbiota in phylum Bacteroidetes to microbiota of Firmicutes phylum preferably includes about 20-60 mg/kg of body weight of fermentable fiber, about 10-30 mg/kg of body weight of beta glucan and about 20-60 mg/kg of body weight of blueberry extracts or any fruit or berry ingredient preparation containing similar phenolics. This formulation is preferably used to control body weight, body composition, and blood glucose regulation, preferably in humans, and is preferably administered orally, preferably twice per day.
    Type: Application
    Filed: August 17, 2012
    Publication date: October 2, 2014
    Applicant: NuMe Health Inc.
    Inventors: Mark L. Heiman, Dean P. Stull, Justin W. Peno
  • Patent number: 8846751
    Abstract: This invention provides an agent for inhibiting production of hepatitis C virus with notable anti-HCV activity and without side-effects. The agent comprises a proanthocyanidin polymer composition illustrated in the following the general formula (1), wherein R1 is hydrogen or hydroxyl, R2 is hydroxyl, R3 is hydrogen when R1 is either hydrogen or hydroxyl, but R3 is possibly hydroxyl when R1 is either hydrogen or hydroxyl to the extent that both R1 and R3 being hydroxyl is at most 40 percents in the proanthocyanidin polymer composition said units of flavan-3-ol being bonded each other in any one of three patterns as follows; (i) a bond between carbon at the position 4 and carbon at the position 8, (ii) a bond between carbon at the position 4 and carbon at the position 6, (iii) a bond between carbon at the position 4 and carbon at the position 8, and between carbon, at the position 2 and oxygen at the position 7.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: September 30, 2014
    Assignees: Miyazaki Enterprise Promotion Organization, Miyazaki Prefecture, Unkai Shuzo Co., Ltd., Minami Nippon Dairy Co-Op Co., Ltd.
    Inventors: Masahiko Takeshita, Hirohito Tsubouchi, Hirofumi Uto, Hiroaki Kataoka, Takanori Kai, Hideaki Hirabaru, Miho Sakai, Ena Akamatsu
  • Patent number: 8840937
    Abstract: A method and composition for reducing the recovery time for a human suffering from mild traumatic brain injury are provided. The composition is a mixture of component supplements that synergistically address the symptoms of the condition and the damage done by the injury.
    Type: Grant
    Filed: February 29, 2012
    Date of Patent: September 23, 2014
    Inventor: Walter Joe Ford, Jr.
  • Publication number: 20140271947
    Abstract: A dietary supplement and method of supplementation comprises a vegetable component consisting essentially of juices extracted from two parts by weight fresh, unpeeled carrots; one part by weight fresh, unpeeled beet root; one part by weight of fresh, unpeeled cucumber; and a selected quantity of aloe vera juice. A cleansing component includes at least one of the following: about 2 fluid ounces (59.1 ml) of lemon juice; about 1.5-2 fluid ounces (44.3 to 59.1 ml) of lime juice; about 1 fluid ounce (29.6 ml) of aloe vera juice; and about 4-6 fluid ounces (118.3 to 177.4 ml) of cranberry juice. The vegetable component is ingested orally twice daily and the cleansing component is ingested orally once daily.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 18, 2014
    Inventor: Delphine Agatha O'Connor-Smith
  • Patent number: 8809400
    Abstract: Disclosed is a pharmaceutical composition for treating oxidative stress comprising a therapeutically effective amount of a substantially pure compound of pterostilbene and a physiologically acceptable carrier. Pterostilbene is administered in an amount between about 2.5 mg to about 10 mg per kilogram of subject body weight. Also disclosed is a method for increasing a working memory of a subject, the method comprising administrating an effective amount of a substantially pure compound of pterostilbene, wherein the working memory for a subject increase and the therapeutic effectiveness is about 10 mg of pterostilbene per kilogram of subject body weight.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: August 19, 2014
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: James A. Joseph, Agnes M. Rimando, Barbara Shukitt-Hale
  • Patent number: 8802163
    Abstract: A natural soap is made using a herbal medicine decoction. The natural soap includes herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multiflorus, blueberry, and Acorus gramineus. A ripening device ripens the herbs in temperatures of 65 to 95° C. for 3 to 15 days, distilled water or soft water is poured onto the herbs, and the herbs mixed with the water are decocted by a decoction maker.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: August 12, 2014
    Inventor: Eun Joo Ko
  • Patent number: 8790727
    Abstract: Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with Morinda citrifolia and iridoids.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: July 29, 2014
    Assignee: Tahitian Noni International, Inc.
    Inventors: Brett Justin West, Claude Jarakae Jensen, Afa Kehaati Palu, Shixin Deng, Jeffrey A. Wasden
  • Publication number: 20140178508
    Abstract: The invention describes stabile anthocyanin compositions, methods to prepare such compositions and also methods of use of such compositions to treat various afflictions. The present invention describes unique compositions of an anthocyanin and a stabilizing compound such that the combination of the two components provides that the anthocyanin does not readily undergo degradation, such as oxidation, pH instability, etc.
    Type: Application
    Filed: December 30, 2013
    Publication date: June 26, 2014
    Applicant: Omnica GmbH
    Inventor: Thomas Eidenberger
  • Publication number: 20140170247
    Abstract: A daily liquid supplement for ocular and body health containing at least one of lutein, zeaxanthin, meso-zeaxanthin and astaxanthin for a human subject for nutritionally supplementing macular pigments is disclosed. The micronized nutrients in a lipid based emulsion are more efficiently absorbed into the bloodstream than conventional supplement formulations resulting in higher serum levels and increased macular pigment.
    Type: Application
    Filed: September 16, 2013
    Publication date: June 19, 2014
    Applicant: Guardion Health Sciences, LLC
    Inventor: Sheldon Hendler
  • Patent number: 8747817
    Abstract: A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: June 10, 2014
    Inventor: William Scott Prendergast
  • Patent number: 8734858
    Abstract: The invention relates to the use of a Myrica gale plant for producing a herbicidal agent or for preparing a herbicidal composition, and also to the corresponding herbicidal compositions and the herbicidal compositions containing a newly demonstrated herbicidal agent.
    Type: Grant
    Filed: July 27, 2009
    Date of Patent: May 27, 2014
    Assignees: Universite Claude Bernard Lyon I, Centre National de la Recherche Scientifique
    Inventors: Jean Popovici, Cédric Bertrand, Gilles Comte
  • Publication number: 20140141088
    Abstract: A water-soluble anti-inflammatory cream is disclosed. The cream is a composition of between about 7.5% and about 30% by weight of a healing oil; between about 1% and about 6% by weight of an herbal extract; between about 0% and about 3.5% by weight of microencapsulated amino acids; and at least 39.4% by weight water.
    Type: Application
    Filed: May 31, 2013
    Publication date: May 22, 2014
    Inventors: Irina V Filippova, Leonid K. Filippov
  • Publication number: 20140134222
    Abstract: The present invention provides a composition comprising an effective amount of benfotiamine and an effective amount of pyridoxamine in a suitable vehicle for topical application. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles, loss of elasticity, and hyperpigmentation caused by chronoaging and/or photoaging of skin, by inhibiting particularly skin damage resulting from reactive carbonyl species (RCS), glycation of skin proteins, formation of advanced glycation endproducts (AGEs) and formation of advanced lipoxidation endproducts (ALEs).
    Type: Application
    Filed: January 17, 2014
    Publication date: May 15, 2014
    Applicant: Tracie Martyn International, Inc.
    Inventor: Marius Morariu
  • Patent number: 8722126
    Abstract: Black currant anthocyanin-containing compositions for foods comprising 1 to 25% by weight of black currant anthocyanin on the basis of solid matters; a process for producing a black currant anthocyanin-containing composition for foods characterized by purifying and concentrating black currant juice employed as a starting material by using a charged reverse osmosis membrane; functional foods and drinks characterized by containing the above compositions for foods; and the above-described compositions for foods and the above-described functional foods and drinks having an effect of improving visual function, a function of improving blood fluidity, and/or a function of lowering blood pressure. The conventional black currant anthocyanin compositions have a low black currant anthocyanin content, strong acidity and poor stability, which makes them unsuitable as additives for foods and drinks.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: May 13, 2014
    Assignee: Meiji Co., Ltd.
    Inventors: Hitoshi Matsumoto, Shigeru Tominaga, Mitsuo Kishi, Takashi Kawakami, Takahisa Tokunaga, Masao Hirayama
  • Patent number: 8709515
    Abstract: The method comprises steps of: providing a nutraceutical including, in combination, 1.13 to 3 mg lutein and 18.8 to 51.2 mg omega fatty acids and 1.9 to 5.2 mg grape seed extract and 1.9 to 5.2 mg alpha lipoic acid; determining the weight of each dose of the components in the combination based upon an amount per kg body weight of the animal patients; and administering 1 dose of nutraceutical per day to animals suffering from ocular health issues including any degenerative retinal disease and diabetic cataracts and prior to and following cataract surgery for the diminishment and prevention of secondary cataracts.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: April 29, 2014
    Inventors: Carmen C. H. Colitz, Terri L. McCalla, Debra A. Smith
  • Patent number: 8679550
    Abstract: Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an IC50 of 3.8 ?L/mL. In vivo bioactivities were evaluated in type 2 diabetic Sprague Dawley rats.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: March 25, 2014
    Assignee: Tahitian Noni International, Inc.
    Inventors: Brett Justin West, Claude Jarakae Jensen, Afa Kehaati Palu, Shixin Deng, Jeffery A. Wasden
  • Publication number: 20140079639
    Abstract: Provided herein are methods of culturing cells in vitro in order to exploit the biochemical production ability of the cells to make metabolites that are evaluated and harvested for their biological effects. Also provided are systems for evaluating extracts from such cultured cells to characterize their biological activity(s), particularly with regard to impact on health, wellbeing, longevity, DNA maintenance, mitochondrial health and/or biogenesis, and so forth. Biologically active extracts, components thereof, and compositions (such as cosmetic or pharmaceutical preparations) made comprising such, are also provided.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Inventor: David H. McDaniel
  • Publication number: 20140044809
    Abstract: The present invention provides antacid compositions and associated methods. In one aspect for example, an antacid composition suitable for delivery to a subject for reducing a digestive condition includes an effective amount of at least one citrate compound, an effective amount of blueberry product, and an effective amount of fruit extract including a member selected from the group consisting of pomegranate extract, bilberry extract, elderberry extract, blueberry extract, and combinations thereof.
    Type: Application
    Filed: February 4, 2013
    Publication date: February 13, 2014
    Inventor: Elliott F. Brainard
  • Publication number: 20140037763
    Abstract: Compositions and methods of use of annatto extracts [350-450 Dalton molecular weight fraction] including tocotrienols and tocopherols with an appropriate spectrum. This spectrum includes but not limited to low alpha tocopherol, high delta- and gamma-tocols, and mixtures with other extracts [350-450 Dalton molecular weight fraction] like palm and rice and/or nutrients.
    Type: Application
    Filed: October 17, 2013
    Publication date: February 6, 2014
    Applicant: AMERICAN RIVER NUTRITION, INC.
    Inventors: Barrie TAN, Jose LLOBRERA
  • Patent number: 8637096
    Abstract: A new treatment for individuals suffering from type 2 diabetes. The formulation used in the treatment includes a mixture of a thiazoleineione, an insulin, cinnamon bark extract, and at least one synergistic supplement selected from the group consisting of blueberry leaf extract, cranberry extract, kelp extract, sugar sea beet extract, acerola berry extract; ginger root extract, black cherry extract, green tea extract, Irish moss extract, aloe vera extract, and Stevia leaf extract. The thiazoleineione is preferably pioglitazone. The insulin is preferably an Insulin Aspart of rDNA origin. It is preferred that the cinnamon bark extract and synergistic supplement be in the form of a liquid concentrate.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: January 28, 2014
    Inventor: Curtis C. Stojan
  • Publication number: 20140010871
    Abstract: A composition for treatment of urinary tract infection derived primarily from pomegranate and cranberry fruit components is disclosed. The composition may be derived from juices, concentrates, liquid extracts, or powdered extracts, e.g. dehydrated pomegranate juice, of pomegranate and cranberry fruits. The concentration of each of the component (i.e. pomegranate product and cranberry product) in the composition is set such as to achieve optimum synergistic effects by increasing urinary tract anti-adhesion activity.
    Type: Application
    Filed: July 3, 2013
    Publication date: January 9, 2014
    Inventor: Ari Mackler
  • Publication number: 20140004214
    Abstract: The invention provides a method of isolating one or more compounds present in fruit juice or seed extracts that have anti-microbial activity.
    Type: Application
    Filed: June 14, 2013
    Publication date: January 2, 2014
    Applicant: Wisconsin Alumni Research Foundation
    Inventors: Brant Lawrence Kedrowski, Teri Shors
  • Publication number: 20130344179
    Abstract: The present invention relates to a food supplement composition for reducing fatigue, and/or improving recovery and resistance to fatigue. The composition comprised of collagen hydrolysate, blueberry extract and liquorice extract.
    Type: Application
    Filed: August 26, 2013
    Publication date: December 26, 2013
    Inventor: Michel Grisé
  • Publication number: 20130344178
    Abstract: A natural shampoo is provided. The natural shampoo is made using a herbal medicine mature decoction which is obtained by putting herbs including lotus roots, lotus leaves, red ginseng, Hippophae rhamnoides leaves and trunk, persimmon leaves, thuja orientalis, ginger, rosemary, black beans, black sesame, aloe, mulberry leaves, Orostachys japonicus, Angelica gigas, green tea, pine needles, mint, pleuropterus multflorus, blueberry, Acorus gramineus, and garlic in a maturing device, maturing the herbs in temperatures of 65 to 95° C. depending on the herb for 3 to 21 days, then pouring distilled water or soft water, and decocting the matured herbs mixed with the water.
    Type: Application
    Filed: June 24, 2013
    Publication date: December 26, 2013
    Inventor: Eun Joo KO
  • Publication number: 20130337092
    Abstract: Phytonutrient based compositions and methods of using the same for preventing, reducing, or treating genetic damage induced by environmental toxins are disclosed. Additionally, said compositions and methods are used to reduce oxidized low density lipoproteins (OxLDL), myeloperoxidase (MPO), and plasminogen activator inhibitor-1 (PAI-1).
    Type: Application
    Filed: May 17, 2013
    Publication date: December 19, 2013
    Applicant: METAPROTEOMICS, LLC
    Inventors: Veera KONDA, Andrea Lyra HELLER, Anu DESAI, Brian CARROLL, Matthew L. TRIPP, Jeffrey S. BLAND
  • Publication number: 20130316025
    Abstract: A composition prepared from a cranberry hull enzyme-treated composition which reduces or inhibits the adhesion of microorganisms to cells having ?-Gal-(1-4)-Gal terminal oligosaccharide receptors for adhesion.
    Type: Application
    Filed: May 25, 2012
    Publication date: November 28, 2013
    Applicants: OCEAN SPRAY CRANBERRIES, INC., THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
    Inventors: Arland T. Hotchkiss, Alberto Nunez, Christina Khoo, Gary D. Strahan
  • Patent number: 8591964
    Abstract: This invention relates to novel compositions comprising as an active ingredient one or more berries, leaves, roots, and/or root barks obtained from one or more plant species of the genus Vaccinium, wherein said plant(s) is/are grown under the following conditions: a. Subject to one or more uninterrupted photoperiod(s) of at least about 18 hours to 24 hours per day for about 60 days during flowering and fruit setting; and; b. Subject to one or more uninterrupted photoperiod(s) of at least about 15 hours per day for about 30 days during fruit ripening and maturity. More particularly, said plant(s) is/are optionally grown at least 7 days past maturity. Further, the compositions of the inventive subject matter optionally may include an additional element comprising an oil from Oncorhynchus species. Further, said compositions may be employed to treat a variety of diseases, disorders, and conditions, as described herein.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: November 26, 2013
    Assignee: Denali Biotechnologies, Inc.
    Inventor: Maureen McKenzie
  • Patent number: 8574640
    Abstract: A method and composition for stimulating the proliferation and differentiation of stem cells is used to self-repair injury in mammals. A supplement is administered having an effective dose of blueberry, carnosine, catechin, green tea extract, VitaBlue, Vitamin D3 or combinations of these. For example, a therapeutic amount of two or more of the supplements may be selected having a synergistic effect, allowing a lower dose to achieve the same or greater effective protection as a higher dose of any one of the supplements.
    Type: Grant
    Filed: October 8, 2010
    Date of Patent: November 5, 2013
    Assignees: University of South Florida, The Department of Veterans Affairs, Natura Therapeutics, Inc.
    Inventors: Cyndy Davis Sanberg, Paula Bickford, Paul Sanberg, Jun Tan, R. Douglas Shytle
  • Publication number: 20130280355
    Abstract: The present invention relates to formulations containing extracts of Vaccinium myrtillus or other species rich in anthocyanosides, Punica granatum, Echinacea, and optionally Krameria triandra. Said formulations are useful in the treatment of disorders of the mouth and its adnexa, the throat and respiratory tract, and in the treatment of influenza.
    Type: Application
    Filed: October 5, 2011
    Publication date: October 24, 2013
    Applicant: INDENA S.P.A.
    Inventors: Ezio Bombardelli, Massimo Ronchi, Paolo Morazzoni
  • Publication number: 20130266638
    Abstract: Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.
    Type: Application
    Filed: June 3, 2013
    Publication date: October 10, 2013
    Inventors: Annette Tobia, Alice Marcy, Bangying Su, Takeshi Niwa
  • Publication number: 20130266662
    Abstract: This invention relates to novel compositions comprising as an active ingredient one or more berries, leaves, roots, and/or root barks obtained from one or more plant species of the genus Vaccinium, wherein said plant(s) is/are grown under the following conditions: (a). Subject to one or more uninterrupted photoperiod(s) of at least about 18 hours to 24 hours per day for about 60 days during flowering and fruit setting; and; (b). Subject to one or more uninterrupted photoperiod(s) of at least about 15 hours per day for about 30 days during fruit ripening and maturity. More particularly, said plant(s) is/are optionally grown at least 7 days past maturity. Further, the compositions of the inventive subject matter optionally may include an additional element comprising an oil from Oncorhynchus species. Further, said compositions may be employed to treat a variety of diseases, disorders, and conditions, as described herein.
    Type: Application
    Filed: March 14, 2013
    Publication date: October 10, 2013
    Inventor: Maureen A. McKenzie
  • Publication number: 20130224298
    Abstract: The invention relates to a novel two-phase preparation for use as a food supplement, dietary substance, and/or medicament. The medical use thereof for helping the immune system fight against viral diseases, especially herpes, is particularly preferred. Said preparation may have two different phases which may be used in a chronologically staggered manner, mutually blocking agents being in different phases and mutually boosting agents being in the same phase.
    Type: Application
    Filed: February 14, 2013
    Publication date: August 29, 2013
    Applicant: NUTRITEAM GMBH
    Inventor: NUTRITEAM GMBH